ThinkEquity Downgrades Allion Healthcare (ALLI) to Hold
More News related to ALLI
- Law Offices of Brian M. Felgoise, P.C. Announces Investigation on Behalf of Shareholders of Allion Healthcare, Inc.
- Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Allion Healthcare, Inc.
- Holzer Holzer & Fistel, LLC Announces Investigation Into Purchase of Allion Healthcare, Inc.
- Trading Review for Allion Healthcare Inc. Issued by Beacon Equity
- Law Office of Brodsky & Smith, LLC Announces Investigation on Behalf of Shareholders of Allion Healthcare, Inc.
More News related to Downgrades
- Scotia Capital Downgrades Grupo Aeroportuario del Centro (OMAB) to Sector Perform
- Goldman Sachs Upgrades Bradesco and Banco do Brasil; Downgrades Bancolombia
- Wedbush Downgrades Burger King (BKC) to Underperform
- Morgan Stanley Upgrades Safeway (SWY), Downgrades SUPERVALU (SVU)
- Pali Research Downgrades Franklin Resources (BEN) to Neutral; Fixed Income Bull Losing Steam
ThinkEquity downgrades Allion Healthcare (Nasdaq: ALLI) from Buy to Hold.
To see more analyst ratings on ALLI Click Here.
Allion Healthcare, Inc., together with its subsidiaries, provides specialty pharmacy and disease management services focused on human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS) patients in the United States.
Related Categories
DowngradesStocks Mentioned
-0.01Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
